These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 9218525)

  • 21. Paraoxonase, a cardioprotective enzyme: continuing issues.
    Getz GS; Reardon CA
    Curr Opin Lipidol; 2004 Jun; 15(3):261-7. PubMed ID: 15166781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the structural and functional effects of monomeric and dimeric human apolipoprotein A-II in high density lipoprotein particles.
    Lund-Katz S; Murley YM; Yon E; Gillotte KL; Davidson WS
    Lipids; 1996 Nov; 31(11):1107-13. PubMed ID: 8934442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase.
    Mackness MI; Arrol S; Abbott C; Durrington PN
    Atherosclerosis; 1993 Dec; 104(1-2):129-35. PubMed ID: 8141836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein AI and high-density lipoprotein have anti-inflammatory effects on adipocytes via cholesterol transporters: ATP-binding cassette A-1, ATP-binding cassette G-1, and scavenger receptor B-1.
    Umemoto T; Han CY; Mitra P; Averill MM; Tang C; Goodspeed L; Omer M; Subramanian S; Wang S; Den Hartigh LJ; Wei H; Kim EJ; Kim J; O'Brien KD; Chait A
    Circ Res; 2013 May; 112(10):1345-54. PubMed ID: 23501697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis.
    Shih DM; Gu L; Xia YR; Navab M; Li WF; Hama S; Castellani LW; Furlong CE; Costa LG; Fogelman AM; Lusis AJ
    Nature; 1998 Jul; 394(6690):284-7. PubMed ID: 9685159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human apolipoprotein A-II reduces atherosclerosis in knock-in rabbits.
    Koike T; Koike Y; Yang D; Guo Y; Rom O; Song J; Xu J; Chen Y; Wang Y; Zhu T; Garcia-Barrio MT; Fan J; Chen YE; Zhang J
    Atherosclerosis; 2021 Jan; 316():32-40. PubMed ID: 33296791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenovirus-mediated expression of human paraoxonase 3 protects against the progression of atherosclerosis in apolipoprotein E-deficient mice.
    Ng CJ; Bourquard N; Hama SY; Shih D; Grijalva VR; Navab M; Fogelman AM; Reddy ST
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1368-74. PubMed ID: 17446441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substitution of the carboxyl-terminal domain of apo AI with apo AII sequences restores the potential of HDL to reduce the progression of atherosclerosis in apo E knockout mice.
    Holvoet P; Danloy S; Deridder E; Lox M; Bernar H; Dhoest A; Collen D
    J Clin Invest; 1998 Jul; 102(2):379-85. PubMed ID: 9664079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolism.
    Francone OL; Gong EL; Ng DS; Fielding CJ; Rubin EM
    J Clin Invest; 1995 Sep; 96(3):1440-8. PubMed ID: 7657816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.
    Zhong S; Goldberg IJ; Bruce C; Rubin E; Breslow JL; Tall A
    J Clin Invest; 1994 Dec; 94(6):2457-67. PubMed ID: 7989603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of apolipoproteins AI, AII, and Cs on the metabolism of membrane and lysosomal cholesterol in macrophages.
    Mahlberg FH; Glick JM; Lund-Katz S; Rothblat GH
    J Biol Chem; 1991 Oct; 266(30):19930-7. PubMed ID: 1657906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes.
    Jiang X; Francone OL; Bruce C; Milne R; Mar J; Walsh A; Breslow JL; Tall AR
    J Clin Invest; 1996 Nov; 98(10):2373-80. PubMed ID: 8941656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of the apoA-II gene locus on HDL levels and fatty streak development in mice.
    Mehrabian M; Qiao JH; Hyman R; Ruddle D; Laughton C; Lusis AJ
    Arterioscler Thromb; 1993 Jan; 13(1):1-10. PubMed ID: 8422330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antioxidant properties of HDL in transgenic mice overexpressing human apolipoprotein A-II.
    Boisfer E; Stengel D; Pastier D; Laplaud PM; Dousset N; Ninio E; Kalopissis AD
    J Lipid Res; 2002 May; 43(5):732-41. PubMed ID: 11971944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Arg123-Tyr166 central domain of human ApoAI is critical for lecithin:cholesterol acyltransferase-induced hyperalphalipoproteinemia and HDL remodeling in transgenic mice.
    Holvoet P; De Geest B; Van Linthout S; Lox M; Danloy S; Raes K; Collen D
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):459-66. PubMed ID: 10669644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.
    Watson AD; Berliner JA; Hama SY; La Du BN; Faull KF; Fogelman AM; Navab M
    J Clin Invest; 1995 Dec; 96(6):2882-91. PubMed ID: 8675659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidized LDL and HDL: antagonists in atherothrombosis.
    Mertens A; Holvoet P
    FASEB J; 2001 Oct; 15(12):2073-84. PubMed ID: 11641234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of human apoAII in transgenic rabbits leads to dyslipidemia: a new model for combined hyperlipidemia.
    Koike T; Kitajima S; Yu Y; Li Y; Nishijima K; Liu E; Sun H; Waqar AB; Shibata N; Inoue T; Wang Y; Zhang B; Kobayashi J; Morimoto M; Saku K; Watanabe T; Fan J
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2047-53. PubMed ID: 19778946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrophage paraoxonase 1 (PON1) binding sites.
    Efrat M; Aviram M
    Biochem Biophys Res Commun; 2008 Nov; 376(1):105-10. PubMed ID: 18762170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-density lipoprotein loses its anti-inflammatory properties during acute influenza a infection.
    Van Lenten BJ; Wagner AC; Nayak DP; Hama S; Navab M; Fogelman AM
    Circulation; 2001 May; 103(18):2283-8. PubMed ID: 11342478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.